scispace - formally typeset
J

Jun Zhang

Researcher at Second Military Medical University

Publications -  13
Citations -  385

Jun Zhang is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Triazole & Fluconazole. The author has an hindex of 11, co-authored 13 publications receiving 349 citations.

Papers
More filters
Journal ArticleDOI

Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.

TL;DR: A series of novel 1,2,4-triazole derivatives with a 4-(4-substitutedphenyl) piperazine side chain were designed and synthesized based on the structure of lanosterol 14α-demethylase (CYP51) and found to be more potent against Candida albicans than control drug fluconazole.
Journal ArticleDOI

Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14α-demethylase (CYP51)

TL;DR: Results of preliminary antifungal tests against eight human pathogenic fungi in vitro showed that all title compounds exhibited activity against fungi tested to some extent.
Journal ArticleDOI

Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14α-demethylase

TL;DR: Based on the results of computational docking to the active site of the cytochrome P450 14alpha-demethylase (CYP51), a series of 1-(1H-1,2,4-triazole-1-yl)-2-(2, 4-difluorophenyl)-3-substituted-2-propanols as analogs of fluconazole were designed, synthesized, and evaluated as antifungal agents.
Journal ArticleDOI

Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents

TL;DR: Results of the preliminary antifungal tests against eight human pathogenic fungi in vitro showed that these compounds exhibited activities to some extent, and some displayed excellent antIFungal activities against C. albicans than reference drug fluconazole.
Journal ArticleDOI

Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.

TL;DR: Preliminary antifungal tests against eight human pathogenic fungi in vitro showed that all the title compounds exhibited excellent activities with broad spectrum.